Concepedia

Publication | Closed Access

Optimal concentration range of golimumab in patients with axial spondyloarthritis.

18

Citations

0

References

2018

Year

Ana Martínez‐Feito, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán, Teresa Jurado‐Guerrero, E. Kneepkens, Gertjan Wolbink, Sergio Martín, Ainhoa Ruiz del Agua, Rosaura Navarro, Araceli Mezcua,
PubMed

Abstract

In patients with axSpA, serum GLM trough levels are associated with disease activity during the first year of treatment. A concentration range of 0.7-1.4mg/L appears to be useful to achieve clinical response to GLM.